3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
20
Prostatic Neoplasms
19
Glioblastoma
18
Breast Neoplasms
18
Squamous Cell Carcinoma of Head and Neck
15
Lung Neoplasms
12
Rectal Neoplasms
11
Oropharyngeal Neoplasms
10
Neoplasms
9
Head and Neck Neoplasms
8
Glioma
8
Astrocytoma
8
Neoplasm Metastasis
7
Sarcoma
6
Esophageal Neoplasms
6
Carcinoma, Squamous Cell
6
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Lymphoma, Follicular
5
Hodgkin Disease
5
Gliosarcoma
5
Esophageal Squamous Cell Carcinoma
5
Carcinoma
5
Burkitt Lymphoma
5
Brain Neoplasms
5
Adenocarcinoma of Lung
5
Adenocarcinoma Of Esophagus
5
Small Cell Lung Carcinoma
4
Pancreatic Neoplasms
4
Nasopharyngeal Carcinoma
4
Interventions
pembrolizumab
3
Paclitaxel
2
Carboplatin
2
ulixertinib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
selinexor
1
sapanisertib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
dostarlimab
1
defactinib
1
dabrafenib
1
copanlisib
1
capivasertib
1
binimetinib
1
adavosertib
1
X-Rays
1
Vaginal Smears
1
VMBP protocol
1
Trastuzumab
1
Sutures
1
Sunitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Radiotherapy
×
90 days
×
Clear all
No trials found.